• Explore /
  • Poster
  • / Survival outcomes for patients (pts) with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with lutetium-177-dotatate (Lu-177) in a Brazilian reference center: A six-year follow-up experience.

Survival outcomes for patients (pts) with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with lutetium-177-dotatate (Lu-177) in a Brazilian reference center: A six-year follow-up experience.

Abstract Video & Slides Poster

Authors

null

Zenaide Silva Souza

Hospital Sírio-Libanês, São Paulo, Brazil;

Zenaide Silva Souza , Camila Bragança Xavier , Luciana Beatriz Mendes Gomes Siqueira , Maria Fernanda Barbosa de Medeiros , Micelange Carvalho de Souza , Maria Dirlei de Souza Begnami , Allan Andresson Lima Pereira , José Flávio Gomes Marin , Carlos Alberto Buchpiguel , Frederico Costa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 642)

DOI

10.1200/JCO.2023.41.4_suppl.642

Abstract #

642

Poster Bd #

G11

Abstract Disclosures

Similar Posters

First Author: Nicholas I. Simon

First Author: Leah Mailly-Giacchetti

First Author: Mitchell W. Lavoie

First Author: Andreja Frilling